Serving the San Francisco-Oakland-Berkeley metro area
34 of 128 GLP-1 clinics in San Francisco prescribe tirzepatide (27% of local providers). Compare pricing, insurance acceptance, and patient reviews to find the right provider.
San Francisco has a population of 873,965 in the San Francisco-Oakland-Berkeley metro area. With a local obesity rate of 20.8%, demand for GLP-1 medications like tirzepatide continues to grow. The city is well-served with 34 providers currently prescribing tirzepatide.
Medicaid coverage: California Medicaid covers GLP-1 medications, which may reduce your out-of-pocket cost for tirzepatide. Contact your plan to verify specific formulary coverage and prior authorization requirements.
Telehealth in California: California permits telehealth prescribing for GLP-1 medications. Providers must hold a California medical license. Medi-Cal covers GLP-1 medications for obesity. 11 tirzepatide providers in San Francisco offer telehealth consultations.
There are 34 clinics in San Francisco, California that prescribe Tirzepatide (Mounjaro/Zepbound) out of 128 total GLP-1 clinics in the area. 17 of these clinics accept insurance.
Tirzepatide (Mounjaro/Zepbound) programs in San Francisco typically cost between $399 and $982 per month. Prices depend on dosage, whether you use branded or compounded versions, and your insurance coverage. California Medicaid may help cover costs for eligible patients.
Yes. 11 tirzepatide providers serving San Francisco offer telehealth consultations. California permits telehealth prescribing for GLP-1 medications. Providers must hold a California medical license. Medi-Cal covers GLP-1 medications for obesity. You can complete your consultation via video call and have medication shipped to your home.
Learn about Tirzepatide (Mounjaro/Zepbound) – dosing, side effects, costs, and FDA approval status.
This site is for educational purposes only and is not medical advice. Always consult a healthcare provider before starting any medication. Full disclaimer
Yes. California Medicaid covers GLP-1 medications including tirzepatide. Coverage details and prior authorization requirements vary by plan. Contact your Medicaid provider to verify tirzepatide is on your formulary.
Yes. Mounjaro and Zepbound (brand names for tirzepatide) are FDA-approved for weight management. Your provider will determine the right dosage based on your health history and goals.
GLP-1 Medications
Compare Ozempic, Wegovy, Mounjaro, and more
